Differential Diagnosis of Cartilaginous Lesions of Bone

被引:32
作者
Suster, David [1 ,2 ]
Hung, Yin Pun [1 ,2 ]
Nielsen, G. Petur [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Dept Pathol, 55 Fruit St, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
关键词
GRANULOSA-CELL TUMOR; CHONDROMYXOID FIBROMA; OLLIER DISEASE; INTEROBSERVER VARIABILITY; MAFFUCCI SYNDROME; BENIGN; CHONDROBLASTOMA; CHONDROSARCOMA; MUTATIONS; ENCHONDROMATOSIS;
D O I
10.5858/arpa.2019-0441-RA
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Context.-Cartilaginous tumors represent one of the most common tumors of bone. Management of these tumors includes observation, curettage, and surgical excision or resection, depending on their locations and whether they are benign or malignant. They can be diagnostically challenging, particularly in small biopsies. In rare cases, benign tumors may undergo malignant transformation. Objective.-To review common cartilaginous tumors, including in patients with multiple hereditary exostosis, Ollier disease, and Maffucci syndrome, and to discuss problems in the interpretation of well-differentiated cartilaginous neoplasms of bone. Additionally, the concept of atypical cartilaginous tumor/chondrosarcoma grade 1 will be discussed and its use clarified. Data Sources.-PubMed (US National Library of Medicine, Bethesda, Maryland) literature review, case review of archival cases at the Massachusetts General Hospital, and personal experience of the authors. Conclusions.-This review has examined primary welldifferentiated cartilaginous lesions of bone, including their differential diagnosis and approach to management. Because of the frequent overlap in histologic features, particularly between low-grade chondrosarcoma and enchondroma, evaluation of well-differentiated cartilaginous lesions should be undertaken in conjunction with thorough review of the imaging studies.
引用
收藏
页码:71 / 82
页数:12
相关论文
共 74 条
  • [1] Discovered on gastrointestinal stromal tumour 1 (DOG1): a useful immunohistochemical marker for diagnosing chondroblastoma
    Akpalo, Hana
    Lange, Claudia
    Zustin, Jozef
    [J]. HISTOPATHOLOGY, 2012, 60 (07) : 1099 - 1106
  • [2] The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma
    Amary, M. Fernanda
    Berisha, Fitim
    Mozela, Rafael
    Gibbons, Rebecca
    Guttridge, Alice
    O'Donnell, Paul
    Baumhoer, Daniel
    Tirabosco, Roberto
    Flanagan, Adrienne M.
    [J]. HISTOPATHOLOGY, 2016, 69 (01) : 121 - 127
  • [3] Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2
    Amary, M. Fernanda
    Damato, Stephen
    Halai, Dina
    Eskandarpour, Malihe
    Berisha, Fitim
    Bonar, Fiona
    McCarthy, Stan
    Fantin, Valeria R.
    Straley, Kimberly S.
    Lobo, Samira
    Aston, Will
    Green, Claire L.
    Gale, Rosemary E.
    Tirabosco, Roberto
    Futreal, Andrew
    Campbell, Peter
    Presneau, Nadege
    Flanagan, Adrienne M.
    [J]. NATURE GENETICS, 2011, 43 (12) : 1262 - U129
  • [4] IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
    Amary, M. Fernanda
    Bacsi, Krisztian
    Maggiani, Francesca
    Damato, Stephen
    Halai, Dina
    Berisha, Fitim
    Pollock, Robin
    O'Donnell, Paul
    Grigoriadis, Anita
    Diss, Tim
    Eskandarpour, Malihe
    Presneau, Nadege
    Hogendoorn, Pancras C. W.
    Futreal, Andrew
    Tirabosco, Roberto
    Flanagan, Adrienne M.
    [J]. JOURNAL OF PATHOLOGY, 2011, 224 (03) : 334 - 343
  • [5] Metastatic Potential of Grade I Chondrosarcoma of Bone: Results of a Multi-institutional Study
    Andreou, Dimosthenis
    Gilg, Magdalena M.
    Gosheger, Georg
    Werner, Mathias
    Hardes, Jendrik
    Pink, Daniel
    Leithner, Andreas
    Tunn, Per-Ulf
    Streitbuerger, Arne
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (01) : 120 - 125
  • [6] Chondroblastoma in adult age
    Angelini A.
    Hassani M.
    Mavrogenis A.F.
    Trovarelli G.
    Romagnoli C.
    Berizzi A.
    Ruggieri P.
    [J]. European Journal of Orthopaedic Surgery & Traumatology, 2017, 27 (6) : 843 - 849
  • [7] Chondroblastoma-like osteosarcoma: a case report and review
    Aycan, Osman Emre
    Vanel, Daniel
    Righi, Alberto
    Arikan, Yavuz
    Manfrini, Marco
    [J]. SKELETAL RADIOLOGY, 2015, 44 (06) : 869 - 873
  • [8] Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone
    Behjati, Sam
    Tarpey, Patrick S.
    Presneau, Nadege
    Scheipl, Susanne
    Pillay, Nischalan
    Van Loo, Peter
    Wedge, David C.
    Cooke, Susanna L.
    Gundem, Gunes
    Davies, Helen
    Nik-Zainal, Serena
    Martin, Sancha
    McLaren, Stuart
    Goodie, Victoria
    Robinson, Ben
    Butler, Adam
    Teague, Jon W.
    Halai, Dina
    Khatri, Bhavisha
    Myklebost, Ola
    Baumhoer, Daniel
    Jundt, Gernot
    Hamoudi, Rifat
    Tirabosco, Roberto
    Amary, M. Fernanda
    Futreal, P. Andrew
    Stratton, Michael R.
    Campbell, Peter J.
    Flanagan, Adrienne M.
    [J]. NATURE GENETICS, 2013, 45 (12) : 1479 - U105
  • [9] Molecular pathology of chondroid neoplasms: part 1, benign lesions
    Bell, W. C.
    Klein, M. J.
    Pitt, M. J.
    Siegal, G. P.
    [J]. SKELETAL RADIOLOGY, 2006, 35 (11) : 805 - 813
  • [10] Improved Differentiation of Benign Osteochondromas from Secondary Chondrosarcomas with Standardized Measurement of Cartilage Cap at CT and MR Imaging
    Bernard, Stephanie A.
    Murphey, Mark D.
    Flemming, Donald J.
    Kransdorf, Mark J.
    [J]. RADIOLOGY, 2010, 255 (03) : 857 - 865